News Listing

We help businesses to launch, grow and scale

AMSBIO announce the launch of a custom service providing access to a suite of powerful spatial biology multi-omics profiling tools.

NanoString GeoMx DSP is a new flexible multi-omics platform that enables reliable quantitative assessment of the spatial heterogeneity within various sample types including FFPE, TMAs, and fresh-frozen tissue - with no prequalification required. Tackling the ...

Jonathan Tobin, a partner at life science venture capital firm Brandon Capital, and Genghis Lloyd-Harris, a senior advisor at life sciences investment firm, Abingworth, have joined Cancer Research Horizons’ Ventures team as advisory investors-in-residence. Jonathan and Genghis will also join the Investment Committee for Cancer Research Horizons’ £30m Seed Fund*, set up to support the formation of ...

Source Genomics White Paper explores the transformative power of multi-omics in genomic research.

The Rosalind Franklin Institute announces Professor Paul Matthews as its new Institute Director.

AMSBIO has announced a new range of customizable ELISA assay kits designed to enable experienced researchers to achieve reliable and reproducible assay results.

Boyds, the global drug development consultancy, has announced the launch of a brand-new podcast series that aims to keep the scientific and clinical community abreast of the latest advancements in cell and gene therapy and drug development.

OBN (UK) Ltd., the not-for-profit membership organisation that catalyses growth for the life sciences industry, is delighted to announce the winners of their 2023 OBN Awards, presented at the Royal Lancaster, London, on Wednesday 22 November.

Touchlight's proprietary doggybone DNA (dbDNA) has been used as a critical starting material for manufacturing of VMB-100, a potency enhanced messenger ribonucleic acid (mRNA) encoding human insulin-like growth factor-1 (IGF-1) to support Versameb’s first-in-human clinical study to treat chronic stress urinary incontinence (SUI).

Plans have been approved by Oxford City Council to create a new landmark timber cycle pavilion in the heart of Oxford North to provide secure long-stay and short-stay spaces for phase 1a of Oxford’s new £700 million innovation district.